Mark Tye Haeberle

Mark Haeberle practices at Associates in Dermatology in Louisville, Kentucky.

Mark Haeberle's NPI, 1558650291, was assigned on April 4, 2011. Mark Haeberle graduated from University of Louisville School of Medicine in 2011. Mark Haeberle holds Kentucky license 47890.

Mark Haeberle's primary practice is Associates in Dermatology, at 3810 Springhurst Blvd, Louisville, KY 40241 in Jefferson County. The practice phone is (502) 583-1749.

Mark Haeberle's primary practice is Associates in Dermatology in Louisville, Kentucky. Mark Haeberle is also affiliated with Spring View Hospital. The medical group on file is Associates in Dermatology. Dmand AI also links Mark Haeberle to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Mark Haeberle practices, 3 sites in all. Vendor and product names are available with a free account.

Dermatology is Mark Haeberle's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Mark Haeberle is licensed in Kentucky.

CMS data shows 4,872 Medicare services from Mark Haeberle across 45 procedure codes in 2024, for 1,371 Medicare patients. Medicare paid $653,022 for them. Every service was in an office.

CMS counts 1,371 Medicare patients who saw Mark Haeberle in 2024. The largest group is 65 to 74, with 659 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 5% are also on Medicaid. Their average risk score is 1.10, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Mark Haeberle's median patient age at 71, with 52% women.

In 2024, Mark Haeberle wrote 1,176 Medicare Part D claims for 476 patients. 87% of them were for generic drugs. CMS names the drug for 1,047 of them, across 23 drugs with 11 or more claims each, at $992,220 in total drug cost. In 2023, CMS named 1,001 claims across 21 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Mark Haeberle for performance year 2024, reported as part of a group. Mark Haeberle accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 151 procedures of melanoma (skin cancer) excision by Mark Haeberle, more than 96% of the clinicians it reports for that procedure.

Removal of nail tissue: 1 to 10 procedures (CMS shows small counts as a range)

Removal or shaving of skin growth: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 10 papers to Mark Haeberle, published from 2015 to 2019. 2015 was the busiest year, with 2. The most frequent topics are Breast Neoplasms, Erythema and Immunohistochemistry. Mark Haeberle has published most often in Am J Dermatopathol. Mark Haeberle's most frequent co-authors are Timothy S. Brown, MD, Courtney Reynolds Schadt, MD and Soon Bahrami, MD.

CMS Open Payments shows 332 general payments to Mark Haeberle from 27 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 94% of the total. Abbvie Inc. paid the most, $1,646.

Mark Haeberle graduated from University of Louisville School of Medicine in 2011.